Group 1: Financial Performance - The company's gross profit margin increased by 2.72 percentage points in 2023 due to improved production efficiency and reduced costs [2] - The profit distribution plan for 2023 proposes a cash dividend of 2 CNY per 10 shares, subject to shareholder approval [4] - R&D expenditure in 2023 was 27.43 million CNY, accounting for 5.85% of total revenue [5] Group 2: Revenue Composition - Revenue breakdown by product category: - Skincare (excluding masks) 89.19% - Masks 5.22% - Hair care 2.66% - Makeup and others 2.15% - Testing services 0.6% - Other business income 0.18% [3] Group 3: Intellectual Property - The company holds a total of 134 authorized patents, including 117 invention patents, primarily related to raw materials, formulations, and manufacturing processes [3] Group 4: Strategic Goals - Future plans focus on enhancing core competitiveness through investments in market expansion, digital operations, technological upgrades, R&D, and talent acquisition [3] - The company aims to improve its market presence and brand recognition both domestically and internationally [6] Group 5: Competitive Advantages - Key competitive advantages include: - Strong R&D capabilities with a dedicated team of 117 personnel, representing 13.76% of total staff [5] - Advanced product testing capabilities with over 200 sets of testing equipment [5] - Implementation of smart manufacturing systems to enhance operational efficiency [5] Group 6: Market Trends - Industry trends indicate rapid growth in demand driven by consumer upgrades, diversification of sales channels, and increasing competitiveness of domestic brands [5]
芭薇股份(837023) - 投资者关系活动记录表